MINOXIDIL

MINOXIDIL
Product Description

5 % foam, Minoxidil, as a vasodilator, increases microcirculation in the hair follicles and stimulates Vascular Endothelial Growth Factor (VEGF), which is possibly responsible for increased capillary permeability and thus a potent metabolic activity in the anagen phase, which:
•increases the diameter of the hair follicles, •stimulates hair growth in the anagen phase, •extends the anagen phase, •shortens the telogen phase, as a result of which the anagen phase (telogen) occurs faster. Applied directly to the scalp stimulates hair growth, increases hair thickness and density.

Read more Show less

Adamed Pharma S.A.

  • Country/Region:
    Poland
  • On CPHI since:
    2015
  • Certificates:
    2
  • Employees:
    1000 - 4999
Company types
Licensee
Manufacturer/Innovator
Primary activities
Pharmaceutical Company (generic finished products)
Pharmaceutical Company (innovator finished products)
View company profile
Categories
more categories Show less
Specifications
  • Supplied from
    Poland
More specifications Fewer specifications
Sales Markets
Show more Show less

Adamed Pharma S.A.

  • Country/Region:
    Poland
  • On CPHI since:
    2015
  • Certificates:
    2
  • Employees:
    1000 - 4999
Company types
Licensee
Manufacturer/Innovator
Primary activities
Pharmaceutical Company (generic finished products)
Pharmaceutical Company (innovator finished products)
View company profile

More Products from Adamed Pharma S.A. (34)

  • SITAGLIPTIN

    Product SITAGLIPTIN

    25mg; 50mg; 100mg coated tablets
  • SITAGLIPTIN + METFROMIN ER

    Product SITAGLIPTIN + METFROMIN ER

    50mg/500mg
    50mg/1000mg
    100mg/1000mg
    ER tablets
  • SOLIFENACIN+TAMSULOSIN OCAS

    Product SOLIFENACIN+TAMSULOSIN OCAS

    6mg/0,4mg ER tablets
  • CANDESARTAN + AMLODIPINE + HCTZ

    Product CANDESARTAN + AMLODIPINE + HCTZ

    Treatment of hypertension, particularly in patients requiring multiple drugs to achieve blood pressure control
  • CYTISINE

    Product CYTISINE


    Smoking cessation aid to reduce nicotine withdrawal symptoms and cravings associated with quitting smoking.
  • EZETIMIBE + ROSUVASTATIN

    Product EZETIMIBE + ROSUVASTATIN

    Treatment of hypercholesterolemia to lower total cholesterol and LDL cholesterol levels
  • RANOLAZINE

    Product RANOLAZINE

    375mg, 500mg, 750mg extended release tablets, Ranolazine is a selective inhibitor of the late inward sodium current. Inhibiting that current leads to reductions in intracellular calcium levels. It is indicated in adults as add-on therapy for the symptomatic treatment of patients with stable angi...
  • OLANZAPINE ODT

    Product OLANZAPINE ODT

    5mg; 10mg; 15mg; 20mg orodispersible tablets
  • PROGESTERONE

    Product PROGESTERONE

    50mg; 100mg; 200mg vaginal tablets

  • RISEDRONATE SODIUM

    Product RISEDRONATE SODIUM

    35mg; 75mg film-coated tablets

  • ROSUVASTATIN CALCIUM

    Product ROSUVASTATIN CALCIUM

    5mg; 10mg; 15mg; 20mg; 30mg; 40 mg tablets

  • AZITHROMYCIN

    Product AZITHROMYCIN

    500mg coated tablets
show all 34 other products

Adamed Pharma S.A. resources (5)

  • Product Portfolio

    Brochure Product Portfolio

    Adamd`s Product Portfolio
  • DAVIPHARM EXPORT LIST 2025

    Brochure DAVIPHARM EXPORT LIST 2025

    Davipharm is a member of the Adamed group. Produced in Vietnam with EU GMP standards. The export products' list to non-stringent & stringent markets. Contact us
  • Adamed Corporate Presentation

    Brochure Adamed Corporate Presentation

    Presentation
  • This is where Polish innovation begins

    Brochure This is where Polish innovation begins

    The history of Adamed is about responding to thekey challenges of modern medicine. This is both ourmission and the direction we have consistently takensince 1986. Every day, we work with numerousscientists on innovative research projects aimed atimproving existing therapies and promoting diseaseprevention and a healthy lifestyle. To achieve ourgoals, we employ the best specialists in the countryand collaborate with leading scientific centres andinstitutions, while employing state-of-the-art technologiesin all areas of our operations.All this makes Adamed a leader in the next-generationpharmaceutical market in Poland. Our productsare available in dozens of markets all over theworld. Even with this success, we have no intentionof resting on our laurels. We continue to evolve andto search for inspiration and unconventional solutions.We encourage you to learn more about AdamedPharma – the place where Polish innovation begins.
  • Adamed Corporate Film

    Video Adamed Corporate Film

    This is where Polish innovation begins
    2025-10-15